Literature DB >> 16806943

Synthesis and cytotoxic activities of beta-carboline amino acid ester conjugates.

Ming Zhao1, Lanrong Bi, Wei Wang, Chao Wang, Michèle Baudy-Floc'h, Jingfang Ju, Shiqi Peng.   

Abstract

Beta-carboline represents a class of compounds with potent anti-tumor activity by intercalating with DNA. To further enhance the cytotoxic potency and bioavailability of beta-carboline, a series of novel beta-carboline amino acid ester conjugates were designed and synthesized, and the cytotoxic activities of these compounds were tested using a panel of human tumor cell lines. In addition, the membrane permeability of these compounds was evaluated in vitro using a Caco-2 cell monolayer model. The beta-carboline amino acid ester conjugates demonstrated improved cytotoxic activity compared to the parental beta-carbolines. In particular, the Lys/Arg conjugates were the most potent analogs with an IC(50) value of 4 and 1 microM against human cervical carcinoma cells. The low interaction energy of Arg conjugate based on molecular modeling may contribute to its enhanced cytotoxicity. Taken together, this study provided new insights into structure-activity relationships in the beta-carboline amino acid ester conjugates and identified the beta-carboline Lys/Arg conjugates as promising lead compounds for further in vivo biological and molecular evaluation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16806943     DOI: 10.1016/j.bmc.2006.06.021

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  13 in total

1.  Synthesis, physical properties and cytotoxicity of stilbene-triazine derivatives containing amino acid groups as fluorescent whitening agents.

Authors:  Maosheng Wan; Shaoli Zhou; Peifu Jiao; Chengbo Cao; Jing Guo
Journal:  J Fluoresc       Date:  2013-06-09       Impact factor: 2.217

2.  Development and characterization of novel 8-plex DiLeu isobaric labels for quantitative proteomics and peptidomics.

Authors:  Dustin C Frost; Tyler Greer; Feng Xiang; Zhidan Liang; Lingjun Li
Journal:  Rapid Commun Mass Spectrom       Date:  2015-06-30       Impact factor: 2.419

Review 3.  Recent trends in targeted anticancer prodrug and conjugate design.

Authors:  Yashveer Singh; Matthew Palombo; Patrick J Sinko
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

4.  Synthesis, Biological Evaluation and Modeling Studies of New Pyrido[3,4-b]indole Derivatives as Broad-Spectrum Potent Anticancer Agents.

Authors:  Shivaputra A Patil; James K Addo; Hemantkumar Deokar; Shan Sun; Jin Wang; Wei Li; D Parker Suttle; Wei Wang; Ruiwen Zhang; John K Buolamwini
Journal:  Drug Des       Date:  2017-03-01

5.  Synthesis, antiproliferative activity and molecular properties predictions of galloyl derivatives.

Authors:  Marciane Maximo da Silva; Marina Comin; Thiago Santos Duarte; Mary Ann Foglio; João Ernesto de Carvalho; Maria Carmo do Vieira; Anelise Samara Nazari Formagio
Journal:  Molecules       Date:  2015-03-25       Impact factor: 4.411

6.  Five new iridoids from roots of Salvia digitaloides.

Authors:  Shwu-Jen Wu; Yu-Yi Chan
Journal:  Molecules       Date:  2014-09-29       Impact factor: 4.411

Review 7.  β-Carboline-based molecular hybrids as anticancer agents: a brief sketch.

Authors:  Jay Prakash Soni; Yogesh Yeole; Nagula Shankaraiah
Journal:  RSC Med Chem       Date:  2021-03-24

8.  The Effects of N-Butyl-1-(4-dimethylamino)phenyl-1,2,3,4-tetrahydro- β -carboline-3-carboxamide against Leishmania amazonensis Are Mediated by Mitochondrial Dysfunction.

Authors:  Hélito Volpato; Vânia Cristina Desoti; Juliana Cogo; Manuela Ribeiro Panice; Maria Helena Sarragiotto; Sueli de Oliveira Silva; Tânia Ueda-Nakamura; Celso Vataru Nakamura
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-13       Impact factor: 2.629

9.  Docking of THPDTPI: to explore P-selectin as a common target of anti-tumor, anti-thrombotic and anti-inflammatory agent.

Authors:  Haimei Zhu; Yuji Wang; Ce Song; Qiqi Feng; Jianhui Wu; Shurui Zhao; Lin Gui; Xiaoyi Zhang; Ming Zhao; Shiqi Peng
Journal:  Oncotarget       Date:  2017-07-19

10.  Design and development of ICCA as a dual inhibitor of GPIIb/IIIa and P-selectin receptors.

Authors:  Haiyan Chen; An Lu; Xiaoyi Zhang; Lin Gui; Yaonan Wang; Jianhui Wu; Hua Feng; Shiqi Peng; Ming Zhao
Journal:  Drug Des Devel Ther       Date:  2018-07-09       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.